Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Bacterial lysis of Staphylococcus aureus refers to the destruction of the cellular integrity of the Gram-positive pathogen S. aureus, leading to cell death and the release of intracellular contents (StatPearls, 2023). This process is primarily mediated by the degradation of the peptidoglycan layer in the bacterial cell wall, which provides the structural strength necessary to withstand high internal osmotic pressure (Nature Reviews Microbiology, 2015). Therapeutic agents achieve this through various mechanisms: beta-lactam antibiotics inhibit the penicillin-binding proteins involved in cell wall synthesis, while glycopeptides bind to peptidoglycan precursors to prevent cross-linking (Merck Manual, 2023). More recently, phage-derived endolysins like Exebacase have been developed to directly digest the cell wall, causing rapid lysis even in non-dividing cells (Frontiers in Microbiology, 2018). While lysis is essential for clearing infections, the rapid release of pro-inflammatory components such as lipoteichoic acid and peptidoglycan fragments can exacerbate host tissue damage and systemic inflammation (StatPearls, 2023).
Inhibition of peptidoglycan cross-linking, binding to cell wall precursors, or direct enzymatic hydrolysis of the peptidoglycan backbone, leading to osmotic rupture (Merck Manual, 2023; Frontiers in Microbiology, 2018).
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Bacterial lysis of Staphylococcus aureus.